Medical Xpress August 3, 2024
Lori Solomon

A novel, water-resistant patch-wearable cardioverter-defibrillator (P-WCD) is safe and effective for patients at risk for sudden cardiac arrest, according to a study published in the Aug. 6 issue of the Journal of the American College of Cardiology.

John Hummel, M.D., from The Ohio State University in Columbus, and colleagues assessed the and clinical effectiveness of a novel P-WCD. The analysis included 290 patients at risk for due to ventricular tachycardia/ who were not candidates for or refused an implantable defibrillator.

The researchers found that the clinically significant cutaneous adverse device effect rate was 2.30 percent, with no severe adverse effects. There...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Survey / Study, Technology, Trends, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article